CA1184116A - Vaccins contre la bronchite infectieuse des volailles et procede de preparation - Google Patents

Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Info

Publication number: CA1184116A
Authority: CA; Canada
Prior art keywords: virus; cnctc; vaccine; ibv; vaccines
Prior art date: 1979-11-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000439895A

Other languages

English (en)

Inventor

Peter Apontoweil

Manfred M. Krasselt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gist Brocades NV

Original Assignee

Gist Brocades NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-11-30

Filing date

1983-10-27

Publication date

1985-03-19

1979-11-30 Priority claimed from NL7908687A external-priority patent/NL7908687A/nl

1980-09-09 Priority claimed from NL8005083A external-priority patent/NL8005083A/nl

1980-11-28 Priority claimed from CA000365730A external-priority patent/CA1184115A/fr

1983-10-27 Application filed by Gist Brocades NV filed Critical Gist Brocades NV

1985-03-19 Application granted granted Critical

1985-03-19 Publication of CA1184116A publication Critical patent/CA1184116A/fr

Status Expired legal-status Critical Current

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 69
238000000034 method Methods 0.000 title claims abstract description 27
208000015181 infectious disease Diseases 0.000 title claims abstract description 24
230000008569 process Effects 0.000 title claims abstract description 21
230000002458 infectious effect Effects 0.000 title claims abstract description 18
238000002360 preparation method Methods 0.000 title claims abstract description 16
206010006451 bronchitis Diseases 0.000 title claims abstract description 15
244000144977 poultry Species 0.000 title claims abstract description 14
241000700605 Viruses Species 0.000 claims abstract description 116
239000000463 material Substances 0.000 claims abstract description 23
239000012530 fluid Substances 0.000 claims abstract description 16
238000004108 freeze drying Methods 0.000 claims abstract description 14
230000002779 inactivation Effects 0.000 claims abstract description 8
239000000203 mixture Substances 0.000 claims abstract description 6
241000711450 Infectious bronchitis virus Species 0.000 claims description 21
235000013594 poultry meat Nutrition 0.000 claims description 12
210000000605 viral structure Anatomy 0.000 claims description 6
239000003381 stabilizer Substances 0.000 claims description 4
239000003242 anti bacterial agent Substances 0.000 claims description 3
244000005700 microbiome Species 0.000 claims description 2
241000711404 Avian avulavirus 1 Species 0.000 claims 1
241000702263 Reovirus sp. Species 0.000 claims 1
230000003115 biocidal effect Effects 0.000 claims 1
235000013601 eggs Nutrition 0.000 description 24
241000287828 Gallus gallus Species 0.000 description 23
235000013330 chicken meat Nutrition 0.000 description 19
238000012360 testing method Methods 0.000 description 11
239000012071 phase Substances 0.000 description 9
239000000725 suspension Substances 0.000 description 8
241000271566 Aves Species 0.000 description 7
241001465754 Metazoa Species 0.000 description 7
201000010099 disease Diseases 0.000 description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
210000002257 embryonic structure Anatomy 0.000 description 6
238000006386 neutralization reaction Methods 0.000 description 6
FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
238000011534 incubation Methods 0.000 description 5
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 5
208000024891 symptom Diseases 0.000 description 5
239000005723 virus inoculator Substances 0.000 description 5
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
101001101328 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 50S ribosomal protein L30 Proteins 0.000 description 4
229930195725 Mannitol Natural products 0.000 description 4
238000003556 assay Methods 0.000 description 4
238000001816 cooling Methods 0.000 description 4
238000001914 filtration Methods 0.000 description 4
239000000594 mannitol Substances 0.000 description 4
229960001855 mannitol Drugs 0.000 description 4
235000010355 mannitol Nutrition 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000003921 oil Substances 0.000 description 4
238000012545 processing Methods 0.000 description 4
238000000746 purification Methods 0.000 description 4
230000000241 respiratory effect Effects 0.000 description 4
238000002255 vaccination Methods 0.000 description 4
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
JDRAOGVAQOVDEB-KTKRTIGZSA-N (3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl) (z)-octadec-9-enoate Chemical compound OC1COC2C(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC21 JDRAOGVAQOVDEB-KTKRTIGZSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241000711573 Coronaviridae Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
LUXUAZKGQZPOBZ-SAXJAHGMSA-N [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O LUXUAZKGQZPOBZ-SAXJAHGMSA-N 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000003053 immunization Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
229940031551 inactivated vaccine Drugs 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000003292 kidney cell Anatomy 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
210000003101 oviduct Anatomy 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
229960000380 propiolactone Drugs 0.000 description 2
210000002345 respiratory system Anatomy 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
210000003437 trachea Anatomy 0.000 description 2
230000029812 viral genome replication Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
101100379067 Caenorhabditis elegans anc-1 gene Proteins 0.000 description 1
235000006696 Catha edulis Nutrition 0.000 description 1
240000007681 Catha edulis Species 0.000 description 1
206010011409 Cross infection Diseases 0.000 description 1
206010029803 Nosocomial infection Diseases 0.000 description 1
NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
230000010530 Virus Neutralization Effects 0.000 description 1
NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
229940046545 animal allergen extract Drugs 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
230000027645 antigenic variation Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
244000144992 flock Species 0.000 description 1
ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
235000013305 food Nutrition 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000003902 lesion Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
229960003255 natamycin Drugs 0.000 description 1
NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
235000010298 natamycin Nutrition 0.000 description 1
239000004311 natamycin Substances 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000002245 particle Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000007918 pathogenicity Effects 0.000 description 1
230000002688 persistence Effects 0.000 description 1
239000010773 plant oil Substances 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000004224 protection Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
230000002311 subsequent effect Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000010998 test method Methods 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA000439895A 1979-11-30 1983-10-27 Vaccins contre la bronchite infectieuse des volailles et procede de preparation Expired CA1184116A (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
NL7908687A NL7908687A (nl)	1979-11-30	1979-11-30	Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.
NL7908687		1979-11-30
NL8005083A NL8005083A (nl)	1980-09-09	1980-09-09	Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.
NL8005083		1980-09-09
CA000365730A CA1184115A (fr)	1979-11-30	1980-11-28	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000439895A Division CA1184116A (fr)	1979-11-30	1983-10-27	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000439895A Division CA1184116A (fr)	1979-11-30	1983-10-27	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Publications (1)

Publication Number	Publication Date
CA1184116A true CA1184116A (fr)	1985-03-19

Family

ID=27166903

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA000439896A Expired CA1183473A (fr)	1979-11-30	1983-10-27	Vaccins contre la brochite infectieuse des volailles et procede de preparation
CA000439895A Expired CA1184116A (fr)	1979-11-30	1983-10-27	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA000439896A Expired CA1183473A (fr)	1979-11-30	1983-10-27	Vaccins contre la brochite infectieuse des volailles et procede de preparation

Country Status (1)

Country	Link
CA (2)	CA1183473A (fr)

1983
- 1983-10-27 CA CA000439896A patent/CA1183473A/fr not_active Expired
- 1983-10-27 CA CA000439895A patent/CA1184116A/fr not_active Expired

Also Published As

Publication number	Publication date
CA1183473A (fr)	1985-03-05

Legal Events

Date	Code	Title	Description
2002-03-19	MKEX	Expiry
2023-05-26	MKEX	Expiry	Effective date: 20020319

Publication	Publication Date	Title
US4645665A (en)	1987-02-24	Live infectious bronchitis vaccine for poultry
US4224412A (en)	1980-09-23	Living virus culture vaccine against canine distemper and method of preparing same
JPH06503708A (ja)	1994-04-28	不活性化マイコプラズマ・ハイオニューモニエ・バクテリンおよびその使用方法
US4904468A (en)	1990-02-27	Canine coronavirus vaccine
CA1184115A (fr)	1985-03-19	Vaccins contre la bronchite infectieuse des volailles et procede de preparation
US4357320A (en)	1982-11-02	Infectious bronchitis vaccine for poultry
US4500638A (en)	1985-02-19	Infectious bronchitis virus strain
EP0975360B1 (fr)	2006-08-02	Coronavirus respiratoire bovin utilise comme vaccin
JP3945842B2 (ja)	2007-07-18	弱毒性ニューカッスル病ウイルスワクチン
GB2092443A (en)	1982-08-18	Chlamydia vaccine against enzootic abortion in ewes
USRE31830E (en)	1985-02-12	Infectious bronchitis vaccine for poultry
CA1184116A (fr)	1985-03-19	Vaccins contre la bronchite infectieuse des volailles et procede de preparation
Rasool et al.	2006	Preparation and evaluation of Vero-cell infectious bursal disease vaccine in Pakistan
USRE32423E (en)	1987-05-19	Infectious bronchitis virus strain
USRE34013E (en)	1992-07-28	Infectious bronchitis vaccine for poultry
JPH01272529A (ja)	1989-10-31	混合生ワクチン
JPS6244528B2 (fr)	1987-09-21
US5667785A (en)	1997-09-16	Vaccine for protection of cats against feline infectious peritonitis
Davelaar et al.	1986	The Diagnosis and Control of Infectious Bronchitis Variant Infections
Makesh et al.	1998	Efficacy of bursal derived killed infectious bursal disease vaccine in experimental chicks
Tavassoli et al.	1970	Comparison of pathogenicity and immunogenicity of two strains (TCND and Montana) of Newcastle disease virus propagated in four tissue cell types
Senthilkumar et al.	2006	ANTIGENIC CONTENT OF VERO CELL ADAPTED INFECTIOUS BURSAL DISEASE VIRUS (IBDV) PRODUCED BY DIFFERENT CULTURE METHODS
NL8005083A (nl)	1982-04-01	Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.
CS254937B1 (sk)	1988-02-15	Bivalentná vakcína proti nákaziivéinu chlamýdiovému a paratýfovému zmeíaniu oviec a sposob jej výroby
CS211190B1 (sk)	1982-01-29	Kmeň virusu Aujeszkyho choroby avirulentný pre ošipané a sposob jeho šťachtenia